Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alan Sunga"'
Publikováno v:
Drug development and industrial pharmacy. 30(1)
SU011248 is an oral, multitargeted receptor tyrosine kinase inhibitor (anti PDGFR, VEGFR, Kit, and Flt3) for the treatment of solid tumors. The powder-in-bottle (PIB) approach was used to accelerate development and introduction into Phase I clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a2da66605ffc04f9ed6a25ee4a160c
https://pubmed.ncbi.nlm.nih.gov/15000426
https://pubmed.ncbi.nlm.nih.gov/15000426
Autor:
Sistla, Anand1,2 (AUTHOR), Sunga, Alan1 (AUTHOR), Phung, Kenneth1 (AUTHOR), Koparkar, Arun1 (AUTHOR), Shenoy, Narmada1 (AUTHOR)
Publikováno v:
Drug Development & Industrial Pharmacy. Jan2004, Vol. 30 Issue 1, p19-25. 7p.